FCH
ABMD

Freestone Capital Holdings’s Abiomed Inc ABMD Stock Holding History

Freestone Capital Holdings’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-850
Closed -$276K – 1230
2020
Q4 		$276K Sell
850
-250
-23% -$69.1K 0.02% 304
2020
Q3 		$305K Sell
1,100
-250
-19% -$72K 0.02% 273
2020
Q2 		$326 Sell
1,350
-761
-36% -$153K ﹤0.01% 270
2020
Q1 		$306 Buy
+2,111
New +$350K 0.01% 307

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Freestone Capital Holdings's ABMD Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 850 shares — an estimated $276K sold.

Freestone Capital Holdings first reported a position in ABMD in Q1 2020 and held it in 4 quarters. The position peaked at $305K in Q3 2020. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 850 Abiomed Inc shares in Q1 2021, an estimated $276K.
  • Freestone Capital Holdings first reported a position in Abiomed Inc in Q1 2020 and held it in 4 quarters.
  • Freestone Capital Holdings's Abiomed Inc position peaked at $305K in Q3 2020.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.